JT aims to build up a distinctive world-class pharmaceutical business driven by R&D, and to win recognition through the development of original new drugs. To this end, the company is actively investing management resources in the expansion and enhancement of its R&D capabilities.
The JT Central Pharmaceutical Research Institute consists of six specialized research facilities that collaborate closely on new drug R&D in four priority areas:(1) glucose and lipid metabolism, (2) virus research, (3) immune disorders and inflammation and (4) bone metabolism.
Under the division of R&D functions between Torii Pharmaceutical and JT, R&D activities pertaining to new compounds have been centralized within JT, while Torii is responsible primarily for improvements to the formulations of existing products, and the development of additional indications. Torii also carries out its own R&D in its specific areas of expertise.
|
|
| JT Central Pharmaceutical Research Institute |
|
| Changes / Renewal
